Ravinder R. Kondreddi
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
FNDR-11124, a broad-spectrum small molecule inhibitor of viral RNA polymerase, restricts replication of SARS-CoV-2 and Influenza virus in vitro and in vivo.
Journal: Antiviral research
Published: January 23, 2026
FNDR-11124, a broad-spectrum small molecule inhibitor of viral RNA polymerase, restricts replication of SARS-CoV-2 and Influenza virus in vitro and in vivo.
Journal: Antiviral research
Published: January 23, 2026
Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library.
Journal: Viruses
Published: May 30, 2025
A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
Journal: Nature
Published: November 27, 2016
PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.
Journal: Antimicrobial agents and chemotherapy
Published: January 04, 2016
Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
Journal: European journal of medicinal chemistry
Published: June 15, 2015
Direct inhibitors of InhA are active against Mycobacterium tuberculosis.
Journal: Science translational medicine
Published: January 09, 2015
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis.
Journal: Science translational medicine
Published: December 06, 2013
Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
Journal: Journal of medicinal chemistry
Published: October 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026